The Expanding Role of Pharmacists in Caring for Nonhospitalized Patients With COVID-19

The Expanding Role of Pharmacists in Caring for Nonhospitalized Patients With COVID-19

Tuesday, January 31, 2023
Webinar -- 12:00 PM ET


  • Introduction
  • The role of the pharmacist in managing nonhospitalized patients with COVID-19
  • Risk stratification
  • COVID-19 treatment guidelines
  • Patient case scenarios
  • Audience question and answer session


Julie Ann Justo, PharmD, MS, FIDSA, BCPS

Clinical Associate Professor
Department of Clinical Pharmacy and Outcomes Sciences
University of South Carolina College of Pharmacy
Infectious Diseases Clinical Pharmacy Specialist
Department of Pharmacy
Prisma Health Richland Hospital
Columbia, South Carolina

Program Overview
This program is designed to overcome gaps in the outpatient management of acute COVID and in understanding the evolving science and best practices in management of post-COVID conditions.

Goal Statement
To improve healthcare professionals’ (HCPs) competence in optimizing outpatient management of COVID-19, including timely diagnosis, risk stratification, and treatment, and to expand HCPs’ ability to apply emerging data on the epidemiology, presentation, and emerging data regarding prevention and management of post-COVID conditions.

Target Audience
This program is intended for physicians, pharmacists, and other HCPs involved in the management of nonhospitalized patients with current or previous COVID-19, including both specialists and primary care providers. This identified target audience will benefit from this education by gaining the knowledge and strategies necessary to individualize outpatient management of acute COVID and post-COVID conditions.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Utilize best practices for risk stratification of nonhospitalized patients with COVID-19 to determine eligibility for outpatient treatment
  • Develop individualized care plans for outpatients diagnosed with SARS-CoV-2 infection based on guideline recommendations, current clinical data, and potential logistical or supply constraints


Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Designation of Credit

CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Pharmacy Education

CCO designates this continuing education activity for 1.0 contact hour (0.1 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number: JA4008176-0000-23-024-L01-P

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Disclosure of Conflicts of Interest 
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.